
Prophase Labs Investor Relations Material
Latest events

Q2 2025
Prophase Labs
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Prophase Labs Inc
Access all reports
ProPhase Labs, Inc. is a diversified company engaged in diagnostic testing, genomics, and consumer health products. Its diagnostic services division operates CLIA-certified labs, offering testing solutions for various health conditions, including infectious diseases. The company also focuses on genomics through its subsidiary, which provides genetic testing and research services aimed at improving personalized healthcare. Additionally, ProPhase Labs develops, markets, and distributes a range of over-the-counter consumer health products, primarily focused on immune support and respiratory health. The company is headquartered in Garden City, New York, and its shares are listed on the NASDAQ.
Key slides for Prophase Labs Inc


Investor Presentation
Prophase Labs Inc


Investor Presentation
Prophase Labs Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
PRPH
Country
🇺🇸 United States